Nanologica AB NICA

OMXSTO · Sweden · Health Technology

SEK 0.3020-0.00 (-1.31%)

Market closed· Oct 1, 2026, 3:11 PM UTC· SEK · Data may be delayed

Company news

Yahoo FinanceJan 29, 2026

Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica

GMP Reactor Operations Reactor systems supporting drug substance manufacturing operations Ghent, Belgium, 29th January 2026 – Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the divestment of its drug substance (API) site in Södertälje, Sweden, to Nanologica AB. The business will operate as a wholly owned subsidiary within the Nanologica Group and will revert to its original name, Syntagon AB. The Söd

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.